GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable shift in how we approach type 2 diabetes . These prescription drugs work by mimicking the body’s inherent GLP-1 process, https://socialwebconsult.com/story7242220/glp-1-a-significant-breakthrough-in-blood-sugar-management